| 14.90 Delayed Data As of Jan 18 |  +1.24 / +9.08%Today’s Change | 4.75 Today|||52-Week Range 15.30 | +43.41% Year-to-Date |
| Cronos Group (CRON) Outpaces Stock Market Gains: What You Should Know Jan 17 / Zacks.com - Paid Partner Content | Can Altria's Expansion in RRPs & Cannabis Enable a Revival? Jan 10 / Zacks.com - Paid Partner Content |
| Zacks Investment Ideas feature highlights: Tilray, Canopy and Cronos Jan 17 / Zacks.com - Paid Partner Content | Cronos Group (CRON) Stock Sinks As Market Gains: What You Should Know Jan 08 / Zacks.com - Paid Partner Content |
| Why Marijuana ETF is on a High in 2019 Jan 16 / Zacks.com - Paid Partner Content | The Top Cannabis Investing Storylines to Watch in 2019 Jan 07 / Zacks.com - Paid Partner Content |
| Tilray Shares Rally as Investor Plans Not to Sell Shares Jan 14 / Zacks.com - Paid Partner Content |
| Previous close | 13.66 |
| Today’s open | 13.97 |
| Day’s range | 13.94 - 15.19 |
| Volume | 23,020,837 |
| Average volume (3 months) | 13,638,470 |
| Market cap | $1.5B |
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -- |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +608.57% |
| P/E ratio | NM |
| Price/Sales | 437.01 |
| Price/Book | 18.48 |
| Today’s change | Today’s % change | |
|---|---|---|
| APHAAphria Inc | +0.20 | +3.09% |
| LJPCLa Jolla Pharmaceuti... | +0.05 | +0.80% |
| CTSOCytosorbents Corp | +0.08 | +1.05% |
| CDXCChromadex Corp | -0.02 | -0.60% |
| Next reporting date | February 27, 2019 |
| EPS forecast (this quarter) | $0.00 |
| Annual revenue (last year) | $3.1M |
| Annual profit (last year) | $1.9M |
| Net profit margin | 61.02% |
Sector Health Technology |
Industry Pharmaceuticals: Other |
Chairman, President & Chief Executive Officer Michael Gorenstein |
Chief Operating Officer David Hsu |
Corporate headquarters Toronto, Ontario |
